1.45  -0.08 (-5.23%)		12-01 15:51
Open: 1.49 High: 1.57 Volume: 24,979		Pre. Close: 1.53 Low: 1.43 Market Cap: 5(M)

Short term
Mid term
Targets	6-month :	1.98	1-year :	2.31
Resists	First :	1.69	Second :	1.98
Pivot price	1.56
Supports	First :	1.24	Second :	1.03
MAs	MA(5) :	1.6	MA(20) :	1.56
	MA(100) :	1.77	MA(250) :	2.15
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	39.1	D(3) :	48.4
RSI	RSI(14): 44.1
52-week	High :	6.55	Low :	1.21

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SILO ] has closed above bottom band by 35.2%. Bollinger Bands are 87.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.57 - 1.58	1.58 - 1.59
Low:	1.4 - 1.42	1.42 - 1.43
Close:	1.44 - 1.46	1.46 - 1.47

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.

Wed, 29 Nov 2023
Domo's (NASDAQ:DOMO) Posts Q3 Sales In Line With Estimates ... - Barchart

Tue, 28 Nov 2023
How Can Digital Twins Get Us Closer To Pharma 40 - BioProcess Online

Tue, 21 Nov 2023
Silo Pharma Inc (SILO) Stock: What Does the Chart Say Tuesday? - InvestorsObserver

Wed, 08 Nov 2023
Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal ... - GlobeNewswire

Mon, 16 Oct 2023
Silo Pharma's SPU-21 Peptide Shows Positive Results Against ... - Yahoo Finance

Wed, 11 Oct 2023
Silo Pharma Initiates Human Factor Study of SPC-15 for the ... - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	3 (M)
Held by Insiders	2.43e+006 (%)
Held by Institutions	14.8 (%)
Shares Short	82 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-4 %
Return on Assets (ttm)	290.7 %
Return on Equity (ttm)	-24.7 %
Qtrly Rev. Growth	72100 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-1.4 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-3 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-0.39

Dividend	0
Forward Dividend	56720
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.